Sign in
ALSE Stock Price, Chart, Stats & News
Alseres Pharmaceuticals, Inc.
Save
Alseres Pharmaceuticals, Inc. (ALSE) does not currently pay a dividend.
398,255
Market cap
–
Current P/E
–
Forward P/E
ALSE chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Biotechnology
Industry
Alseres Pharmaceuticals, Inc. focuses on creating both diagnostic and therapeutic solutions, with a primary emphasis on ailments affecting the central nervous system. Their flagship experimental compound is Altropane, a molecular imaging agent developed for identifying and diagnosing Parkinson's disease and dementia. Founded in 1972, the company was previously known as Boston Life Sciences, Inc. before officially changing its name to Alseres Pharmaceuticals, Inc. in June 2007.
Similar securities
Based on sector and market capitalization
Report issue